Cite

HARVARD Citation

    El Zawahry, H. et al. (n.d.). Clinical parameters significantly predict cardiac toxicity of adjuvant Tastuzumab in Her 2 neu positive breast cancer patients. Breast. pp. S23-. [Online]. 
  
Back to record